HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.

AbstractOBJECTIVES:
To compare the expression of nerve growth factor (NGF) and its high-affinity receptor trkA in normal ovaries and in epithelial ovarian carcinomas. Given NGF acts as an angiogenic factor through a vascular endothelial growth factor (VEGF)-mediated mechanism in several types of tissues, we examined whether NGF regulates the expression of VEGF isoforms in epithelial ovarian cancer (EOC).
METHODS:
The expression and localization of NGF and tyrosine kinase receptor A (trkA) in normal ovarian samples and in ovarian cancer samples were analyzed by RT-PCR and immunohistochemistry. NGF regulates the expression of three VEGF isoforms (VEGF(121), VEGF(165) and VEGF(189)); these were examined using RT-PCR in explants of EOC and ELISA in culture media.
RESULTS:
TrkA mRNA levels were over-expressed in ovarian cancer compared to normal ovarian samples, whereas NGF mRNA levels remained unchanged. NGF and trkA proteins were absent or found in very low levels in normal ovarian surface epithelium (OSE), whereas they were highly expressed in epithelial cells of EOC. Additionally, NGF stimulated the expression of VEGF isoforms in cancer explants. The effect was dose-dependent and inhibited by a NGF antibody and by K(252a), a trk receptor inhibitor.
CONCLUSION:
The abundance of NGF and trkA receptors in epithelial cells of EOC, together with the ability of NGF to increase VEGF expression strongly suggests an autocrine role of NGF in EOC. These findings suggest that blocking neurotrophin action could be a therapeutic target in treating ovarian cancer.
AuthorsXimena Campos, Yenny Muñoz, Alberto Selman, Roberto Yazigi, Leonor Moyano, Caroline Weinstein-Oppenheimer, Hernán E Lara, Carmen Romero
JournalGynecologic oncology (Gynecol Oncol) Vol. 104 Issue 1 Pg. 168-75 (Jan 2007) ISSN: 0090-8258 [Print] United States
PMID16935322 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Nerve Growth Factor
  • Receptor, trkA
Topics
  • Adult
  • Female
  • Humans
  • Immunohistochemistry
  • Middle Aged
  • Nerve Growth Factor (biosynthesis, genetics, metabolism)
  • Ovarian Neoplasms (enzymology, genetics, metabolism)
  • Ovary (enzymology, metabolism)
  • RNA, Messenger (biosynthesis, genetics)
  • Receptor, trkA (biosynthesis, genetics, metabolism)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Vascular Endothelial Growth Factor A (biosynthesis, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: